Vitacimin | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Vitacimin
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Vitacimin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

58 API Suppliers, 9 USDMF, 9 CEP/COS, 14 JDMF, 5 EU WC, 6 KDMF, 5 NDC API, 37 Listed Suppliers, $ API Reference Price

58 API Suppliers
9 USDMF
9 CEP/COS
14 JDMF
5 EU WC
6 KDMF
5 NDC API
37 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

16 Drugs in Development

16 Drugs in Development

FINISHED DOSAGE FORMULATIONS

333 FDF Dossiers, 20 FDA Orange Book, 53 Europe, 9 Canada, 64 South Africa, 187 Listed Dossiers

333 FDF Dossiers
20 FDA Orange Book
53 Europe
9 Canada
64 South Africa
187 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 25,000MG/50ML (500MG/ML), SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL
SOLUTION;INTRAVENOUS - 25,000MG/50ML (500MG/ML)
SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML
SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML
INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL
INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 6 Evonik, 14 Rochem International Inc, 23 SPI Pharma, 29 DKSH, 2 Pharm-RX Chemical, 11 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 2 Kewpie Corporation, 13 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 16 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 36 BASF, 2 Bioplus Life Sciences, 2 Clariant, 13 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 13 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 34 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 22 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 13 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 39 Roquette, 16 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

116 Fillers, Diluents & Binders, 66 Coating Systems & Additives, 53 Thickeners and Stabilizers, 50 Taste Masking, 44 Solubilizers, 42 Direct Compression, 39 Parenteral, 37 Controlled & Modified Release, 35 Disintegrants & Superdisintegrants, 33 Film Formers & Plasticizers, 32 Topical, 32 Granulation, 24 Chewable & Orodispersible Aids, 24 Lubricants & Glidants, 18 Co-Processed Excipients, 16 Emulsifying Agents, 16 Rheology Modifiers, 10 API Stability Enhancers, 9 Empty Capsules, 7 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

116 Fillers, Diluents & Binders
66 Coating Systems & Additives
53 Thickeners and Stabilizers
50 Taste Masking
44 Solubilizers
42 Direct Compression
39 Parenteral
37 Controlled & Modified Release
35 Disintegrants & Superdisintegrants
33 Film Formers & Plasticizers
32 Topical
32 Granulation
24 Chewable & Orodispersible Aids
24 Lubricants & Glidants
18 Co-Processed Excipients
16 Emulsifying Agents
16 Rheology Modifiers
10 API Stability Enhancers
9 Empty Capsules
7 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 27 News #PharmaBuzz

1 Data Compilation #PharmaFlow
27 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 28 Regulatory FDF Prices

1 US Medicaid Prescriptions
28 Regulatory FDF Prices

MARKET PLACE

178 APIs, 34 FDF Dossiers, 13 EXCIPIENTS

178 APIs
34 FDF Dossiers
13 EXCIPIENTS

PATENTS & EXCLUSIVITIES

11 US Patents

11 US Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 2 USP, 3 JP, 6 Others

5 EDQM
2 USP
3 JP
6 Others

ANALYTICAL

11 Analytical Methods

11 Analytical Methods

$ API Ref.Price (USD/KG) : 12 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

11 All

01 11SALIX

filter Patent Number Reset all filters

11 All

01 18999313

02 19326969

03 19592252

04 19707297

05 110016504

06 110646512

07 110780112

08 110792306

09 110918723

10 111529368

11 112083179

filter API Patent Reset all filters

11 All

01 11Blank

filter FDF Patent Reset all filters

11 All

01 9Y

02 2Blank

filter Expiration Date Reset all filters

11 All

01 32032-03-09

02 12032-03-25

03 12032-08-11

04 62033-09-10

Product Main Page

01

SALIX

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

Bio-Europe Spring

Not Confirmed

SALIX

Bio-Europe Spring

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-09-10

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 9326969

Drug Substance Claim :

Drug Product Claim :

Application Number : 209381

Patent Use Code : U-2310

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-09-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

SALIX

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

Bio-Europe Spring

Not Confirmed

SALIX

Bio-Europe Spring

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-08-11

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 9592252

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209381

Patent Use Code : U-2310

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-08-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

SALIX

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

Bio-Europe Spring

Not Confirmed

SALIX

Bio-Europe Spring

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-03-09

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 11529368

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209381

Patent Use Code : U-2310

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

SALIX

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

Bio-Europe Spring

Not Confirmed

SALIX

Bio-Europe Spring

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-03-09

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 10792306

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209381

Patent Use Code : U-2310

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

SALIX

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

Bio-Europe Spring

Not Confirmed

SALIX

Bio-Europe Spring

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-09-10

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 10918723

Drug Substance Claim :

Drug Product Claim :

Application Number : 209381

Patent Use Code : U-2310

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-09-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

SALIX

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

Bio-Europe Spring

Not Confirmed

SALIX

Bio-Europe Spring

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-09-10

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 12083179

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209381

Patent Use Code : U-2310

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-09-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

SALIX

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

Bio-Europe Spring

Not Confirmed

SALIX

Bio-Europe Spring

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-03-09

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 10780112

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209381

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

SALIX

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

Bio-Europe Spring

Not Confirmed

SALIX

Bio-Europe Spring

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-09-10

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 10016504

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209381

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-09-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

SALIX

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

Bio-Europe Spring

Not Confirmed

SALIX

Bio-Europe Spring

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-03-25

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 10646512

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209381

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

SALIX

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

Bio-Europe Spring

Not Confirmed

SALIX

Bio-Europe Spring

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-09-10

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 9707297

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209381

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-09-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!